Documentos relacionados

1. Evolution of Antiphospholipid Syndrome.
2. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.
3. Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.
4. Antiphospholipid Syndrome and Kidney Involvement.
5. High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.
6. Surface Geometry of Cargo-less Gold Nanoparticles Is a Driving Force for Selective Targeting of Activated Neutrophils to Reduce Thrombosis in Antiphospholipid Syndrome.
7. Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
8. Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experience.
9. Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study.
10. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.